Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Episode 26 December 07, 2022 00:39:02
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.
Few & Far Between
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Dec 07 2022 | 00:39:02

/

Show Notes

"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can think creatively about the challenges of the cell therapy space." - Chris Min, Longeveron

Biorasi welcomes Chris Min to the Few & Far Between podcast for an inside look at the cell therapy industry and the importance of finding the right team to support your clinical trials. 

Other Episodes

Episode 27

January 31, 2023 00:38:55
Episode Cover

Episode 27, Part 2: Jamie Heywood, Biotech Engineer and Entrepreneur

"Humans have the right to study themselves." - Jamie Heywood, CEO at Alden Scientific Welcome back to Part 2 of our special Few &...

Listen

Episode 31

June 20, 2023 00:44:32
Episode Cover

Episode 31: Pam Cusick, SVP, Rare Patient Voice

"What can I contribute that my doctor can't contribute? And that's a real 'a-ha' moment when we share with them how they're the experts...

Listen

Episode 5

July 07, 2021 00:51:14
Episode Cover

Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development...

Listen